+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Progressive Supranuclear Palsy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768158
  • Report
  • 66 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • AB Science SA
  • AbbVie Inc
  • Alectos Therapeutics
  • Allon Therapeutics Inc.
  • AlzProtect SAS
  • Biogen Inc
  • MORE
The global clinical trial report- “2019 Progressive Supranuclear Palsy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Progressive Supranuclear Palsy. It presents in-depth analysis of Progressive Supranuclear Palsy clinical trials across markets and companies. The research work is for providing complete understanding into trends in Progressive Supranuclear Palsy.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Progressive Supranuclear Palsy clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Progressive Supranuclear Palsy

The research work is prepared through extensive and continuous research on Progressive Supranuclear Palsy trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Progressive Supranuclear Palsy patients are identified
  • The report includes panorama of Progressive Supranuclear Palsy clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Progressive Supranuclear Palsy clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Science SA
  • AbbVie Inc
  • Alectos Therapeutics
  • Allon Therapeutics Inc.
  • AlzProtect SAS
  • Biogen Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Progressive Supranuclear Palsy Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Progressive Supranuclear Palsy Clinical Trials by Region
2.2.2 Average Enrollment of Progressive Supranuclear Palsy Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Progressive Supranuclear Palsy Treatment, 2019

3. Region wise Progressive Supranuclear Palsy Clinical Trials
3.1 Asia Pacific Progressive Supranuclear Palsy Clinical Trials by Country
3.2 Europe Progressive Supranuclear Palsy Clinical Trials by Country
3.3 North America Progressive Supranuclear Palsy Clinical Trials by Country
3.4 Middle East and Africa Progressive Supranuclear Palsy Clinical Trials by Country
3.5 South and Central America Progressive Supranuclear Palsy Clinical Trials by Country

4. Progressive Supranuclear Palsy Clinical Trial Trends
4.1 Start Year wise Progressive Supranuclear Palsy Clinical Trials
4.2 Phase wise Progressive Supranuclear Palsy Clinical Trials
4.3 Trial Status wise Progressive Supranuclear Palsy Clinical Trials
4.4 Trial Type wise Progressive Supranuclear Palsy Clinical Trials

5. Progressive Supranuclear Palsy Average Enrollment Trends
5.1 Average Enrollment in Progressive Supranuclear Palsy Trials by Year
5.2 Average Enrollment in Progressive Supranuclear Palsy Trials by Phase
5.3 Average Enrollment in Progressive Supranuclear Palsy Trials by Status
5.4 Average Enrollment in Progressive Supranuclear Palsy Trials by Type of Trial

6. Companies Participating in Progressive Supranuclear Palsy Clinical Trials
6.1 Progressive Supranuclear Palsy Trials by Sponsor Type
6.2 Progressive Supranuclear Palsy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Progressive Supranuclear Palsy Trials- Phase 1
7.2 Progressive Supranuclear Palsy Trials- Phase 2
7.3 Progressive Supranuclear Palsy Trials- Phase 3
7.4 Progressive Supranuclear Palsy Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Progressive Supranuclear Palsy Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Figure 5: Europe - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Figure 7: North America - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Figure 9: Progressive Supranuclear Palsy Clinical Trials by Phase
Figure 10: Progressive Supranuclear Palsy Clinical Trials by Trial Status
Figure 11: Progressive Supranuclear Palsy Clinical Trials by Type
Figure 12: Progressive Supranuclear Palsy Clinical Trials by Sponsor Type
Figure 13: Progressive Supranuclear Palsy Clinical Trials by Leading Sponsors
Figure 14: Progressive Supranuclear Palsy Average Enrollment by Phase
Figure 15: Progressive Supranuclear Palsy Average Enrollment by Trial Status
Figure 16: Progressive Supranuclear Palsy Average Enrollment by Type
Figure 17: Progressive Supranuclear Palsy- Average Enrolment by Type of Sponsors
Figure 18: Progressive Supranuclear Palsy- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Progressive Supranuclear Palsy Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Table 5: Europe - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Table 7: North America - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Progressive Supranuclear Palsy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Progressive Supranuclear Palsy Average Enrollment by Phase
Table 15: Progressive Supranuclear Palsy Average Enrollment by Trial Status
Table 16: Progressive Supranuclear Palsy Average Enrollment by Type
Table 17: Progressive Supranuclear Palsy- Average Enrolment by Type of Sponsors
Table 18: Progressive Supranuclear Palsy- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AB Science SA
  • AbbVie Inc
  • Acadia Pharmaceuticals Inc
  • Alectos Therapeutics
  • Allon Therapeutics Inc.
  • AlzProtect SAS
  • Biogen Inc
  • Merz Pharma GmbH & Co KgaA
  • Mithridion Inc
  • TauRx Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768158
Adroll
adroll